1. Poster

    Prise en charge d’une escarre récalcitrante par un pansement HydroBalance*

    Poster presented at CPC 2009 18.01.2009 Paris, France
    Products Suprasorb X
  2. Poster

    Evaluation clinique d’un pansement à base de cellulose et de polyhexanide

    Poster presented at CPC 2009 18.01.2009 Paris, France
  3. Poster

    L'évaluation des antiseptiques utilisés pour les plaies dans les conditions de tests de provocation de résistance avec des souches internationales de SARM

    Poster presented at CPC 2009 18.01.2009 Paris, France
  4. Poster

    Capacité de fixation de collagène d’origines différentes pour PDGF-BB

    Poster presented at CPC 2009 18.01.2009 Paris, France
  5. Journal article

    The use of Flivasorb® in highly exuding wounds

    British journal of nursing (Mark Allen Publishing) 2009 18 (15)

    Exudate can be an excellent indicator of what is happening within a wound and, therefore, provides valuable information during patient assessment. The volume, consistency, and particularly odour and colour, of any exudate will inform the practitioner about bacterial contamination, infection and stage of healing (Hampton and Collins, 2003). However, in the chronic wound, exudate must be effectively managed if the optimal moist environment necessary for wound healing is to be created, the negative effects of chronic exudate on fibroblasts are to be avoided (Phillips et al, 1998), and the surrounding skin protected from the risks of maceration (White, 2006). It is, therefore, important to understand chronic exudate and its effects so that appropriate treatment for the wound and peri-wound area is provided. Flivasorb® (Activa Healthcare) dressings, which include superabsorber particles, can absorb the exudate and retain it firmly within the dressing, ensuring that the potentially damaging chronic wound exudate does not reflect back onto the wound, causing maceration. This article will describe the role of exudates in wound healing, the problems associated with chronic wound exudates and how Flivasorb dressings with superabsorbent particles can provide an optimum healing environment in highly exuding wounds.

    Products Vliwasorb
    Further languages
  6. Journal article

    Flivasorb® and the management of exudate

    Wounds UK 2009 5 (2) 63 66

    Wound care provides many challenges but none moreso than the management of high levels of exudate. The challenge is not only to be cost-effective and prevent maceration, but to improve the quality of life for the patient. Chronic wound fluid can be damaging to the wound healing process giving an added problem. This article examines the properties of Flivasorb® (Activa Healthcare), a wound dressing containing super absorbent polymer particles which not only absorbs high levels of exudate, but can retain the damaging particles in exudate, locking them inside the dressing.

    Products Vliwasorb
  7. Journal article

    Treating venous ulceration

    Journal of Community Nursing 2009 23 (6) 34 37
  8. Journal article

    VIABILITY AND PROLIFERATION OF FIBROBLASTS, KERATINOCYTES AND HACAT-CELLS INFLUENCED BY POLLHEXANTDE

    Wound Rep Reg 2009 17 83
    Further versions
    Further languages
  9. Journal article

    QUELLE COMPRESSION SUR DES PATIENT$ IMMOBILES: ALLONGEMENT COURT OU ALLONGEMENT LONG?

    LA REVUE FRANCOPHONE OE GERIATRIE ET OE GERONTOLOGIE 2009 155 (16) 278 283
  10. Journal article

    Development and Implementation of a Clinical Pathway To Improve Venous Leg Ulcer Treatment

    Wounds 2009 21 (5) 127 133